Hester E de Melker
Overview
Explore the profile of Hester E de Melker including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
200
Citations
2851
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Huiberts A, de Bruijn S, Andeweg S, Hoeve C, Schipper M, de Melker H, et al.
Nat Commun
. 2025 Mar;
16(1):1923.
PMID: 40038286
Fatigue is one of the most common persistent symptoms of SARS-CoV-2 infection. We aimed to assess fatigue during and after a SARS-CoV-2 infection by age, sex, presence of a medical...
2.
Laarman C, Hahne S, de Melker H, Knol M
PLoS One
. 2025 Jan;
19(12):e0311229.
PMID: 39774370
Introduction: Most studies on risk factors for a SARS-CoV-2 infection were conducted in the pre-vaccination era with many non-pharmaceutical prevention measures in place. We investigated risk factors for symptomatic SARS-CoV-2...
3.
Immink M, van der Maas N, Bekker M, de Melker H, Den Hartog G, Rots N, et al.
Open Forum Infect Dis
. 2024 Dec;
12(1):ofae717.
PMID: 39720465
A post hoc analysis of maternally derived antibodies at birth and age 2 months following second trimester maternal Tdap vaccination between 20 and 24 weeks' gestational age (GA) showed a...
4.
Huiberts A, Oosting I, de Melker H, van de Wijgert J, Grobbee D, van den Hof S, et al.
Epidemiol Infect
. 2024 Dec;
153():e5.
PMID: 39676571
This study explored the effect of SARS-CoV-2 infection and COVID-19 vaccination during pregnancy on neonatal outcomes among women from the general Dutch population. VASCO is an ongoing prospective cohort study...
5.
Backer J, Vos E, Den Hartog G, van Hagen C, de Melker H, van der Klis F, et al.
Euro Surveill
. 2024 Oct;
29(43).
PMID: 39450517
BackgroundThe first wave of the COVID-19 pandemic in 2020 was largely mitigated by limiting contacts in the general population. In early 2022, most contact-reducing measures were lifted.AimTo assess whether the...
6.
Kusters J, Schim van der Loeff M, van Benthem B, King A, de Melker H, Heijman T, et al.
BMC Med
. 2024 Oct;
22(1):469.
PMID: 39407233
Background: The Netherlands is one of few countries worldwide which has used the bivalent HPV vaccine for girls-only for over a decade. This allows assessment of vaccine effectiveness (VE) against...
7.
Huiberts A, Hoeve C, Kooijman M, de Melker H, Hahne S, Grobbee D, et al.
BMJ Open
. 2024 Oct;
14(10):e085388.
PMID: 39401962
Purpose: VAccine Study COVID-19 (VASCO) is a cohort study with a 5-year follow-up that was initiated when COVID-19 vaccination was introduced in the Netherlands. The primary objective is to estimate...
8.
de Gier B, van de Kassteele J, van Asten L, Schoffelen A, Hooiveld M, Te Wierik M, et al.
Euro Surveill
. 2024 Oct;
29(40).
PMID: 39364598
BackgroundAfter most COVID-19 pandemic control measures were lifted in 2022, many infectious diseases re-emerged. An increase in invasive group A streptococcal (iGAS) infections among adults and young children was reported...
9.
Kusters J, Schim van der Loeff M, Heijne J, King A, de Melker H, Heijman T, et al.
J Infect Dis
. 2024 Sep;
231(1):e165-e176.
PMID: 39271142
Background: Between 2009-2021, bivalent human papillomavirus (HPV) vaccination was offered to girls in the Netherlands. We studied the impact of girls-only HPV vaccination on genital HPV prevalence among young adults....
10.
Immink M, Bekker M, de Melker H, Den Hartog G, Rots N, van Gageldonk P, et al.
JAMA Netw Open
. 2024 Jul;
7(7):e2424608.
PMID: 39078627
Importance: Maternal tetanus, diphtheria, and acellular pertussis (Tdap) vaccination protects newborns against severe pertussis. Data on transplacental antibody transfer on Tdap vaccination before 24 weeks' gestation remain scarce and are...